Literature DB >> 1929926

Ocular findings associated with a rhodopsin gene codon 58 transversion mutation in autosomal dominant retinitis pigmentosa.

G A Fishman1, E M Stone, L D Gilbert, P Kenna, V C Sheffield.   

Abstract

Eight members of a family with autosomal dominant retinitis pigmentosa were found to have a cytosine-to-guanine (C-to-G) transversion mutation in the second nucleotide of codon 58 of the rhodopsin gene, causing a substitution of the amino acid arginine for threonine. Five of these individuals were examined clinically. There was a distinct phenotypic expression of the gene defect within this family that included a regional predilection for pigmentary changes in the inferior and inferonasal parts of the retina, as well as field impairment predominantly in the superior hemisphere. Characteristic electroretinographic recordings and psychophysical threshold profiles also helped to identify this phenotype that, on a relative basis, causes less severe photoreceptor cell functional impairment than often occurs in other subtypes of retinitis pigmentosa. This report documents the association of a clinically recognizable phenotype in a family with autosomal dominant retinitis pigmentosa and a specific gene defect at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929926     DOI: 10.1001/archopht.1991.01080100067044

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

1.  Nine generations of a family with autosomal dominant retinitis pigmentosa and evidence of variable expressivity from census records.

Authors:  M Jay; A C Bird; A N Moore; B Jay
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

2.  Sector Retinitis Pigmentosa caused by mutations of the RHO gene.

Authors:  Ting Xiao; Ke Xu; Xiaohui Zhang; Yue Xie; Yang Li
Journal:  Eye (Lond)       Date:  2018-11-02       Impact factor: 3.775

Review 3.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

4.  Homeless people and psychiatric care.

Authors:  D Double
Journal:  BMJ       Date:  1991-07-13

5.  Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Elizabeth A M Windsor; Waldo Herrera; D Alan White; Shalesh Kaushal; Anjani Naidu; Alejandro J Roman; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

6.  Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study.

Authors:  A T Moore; F Fitzke; M Jay; G B Arden; C F Inglehearn; T J Keen; S S Bhattacharya; A C Bird
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

7.  Abnormal dark adaptation kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation.

Authors:  A T Moore; F W Fitzke; C M Kemp; G B Arden; T J Keen; C F Inglehearn; S S Bhattacharya; A C Bird
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

8.  Autosomal dominant retinitis pigmentosa mapping to chromosome 7p exhibits variable expression.

Authors:  R Y Kim; F W Fitzke; A T Moore; M Jay; C Inglehearn; G B Arden; S S Bhattacharya; A C Bird
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

9.  Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosa.

Authors:  K T Oh; D M Oh; R G Weleber; E M Stone; A Parikh; J White; K A Deboer-Shields; L Streb; C Vallar
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

10.  Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations.

Authors:  Samuel G Jacobson; David B McGuigan; Alexander Sumaroka; Alejandro J Roman; Michaela L Gruzensky; Rebecca Sheplock; Judy Palma; Sharon B Schwartz; Tomas S Aleman; Artur V Cideciyan
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-09-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.